Grace Tx (GRCE) Tezkor likvidlik koeffitsiyenti
Grace Therapeutics, Inc. (GRCE) kompaniyasining 11.18 indikatori bilan bozor narxlarining harakati, rahbariyati patentlarni himoya qilish va dori vositalarini ishlab chiqishdagi byurokratik to'siqlarni yengib o'tishga e'tibor qaratgan kompaniya dinamikasini aks ettiradi. Biznes noyob patologiyalarni davolash uchun moddalarni miyaga yetkazib berishning noyob usullarini ishlab chiqmoqda. Hozirgi model tadqiqot va ishlanmalar sikllariga tayanadi, chunki dori vositalari savdosidan tijorat daromadlari hali shakllanmagan.
%20Kritik%20likvidlik&width=1200&height=400&colorIndex=0&v=mvujvhid.si-7ayy9s0&start=20220704&end=20261030&filename=GURU_Markets_-_GRCE_-_Grace-Therapeutics-Inc._-_Critical-Liquidity "Tezkor likvidlik: Grace Therapeutics (GRCE) 29.10.2024 - 30.10.2026 uchun | 👁️GURU.Markets👁️")
Grace Therapeutics, Inc. (GRCE) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti
- bozor qiymati va tahlilchilarning maqsadli prognozi:
- bozor kapitallashuvi tafsilotlari:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning kapitalga nisbati Grace Therapeutics, Inc.|GRCE - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati gracetx.com|GRCE - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans qiymatiga nisbati Grace Tx|GRCE - Kompaniyaning uzoq muddatli kredit va qarzlari|Kompaniyaning qisqa muddatli majburiyatlari Grace Therapeutics|Tezkor likvidlik koeffitsiyenti gracetx.com
- foyda va bozor multiplikatorlari tafsilotlari:
Kompaniyaning har tomonlama tahlili:Grace Therapeutics Inc, GRCE
Tezkor koeffitsient kompaniyaning past likvidlikka ega zaxiralarni hisobga olmagan holda, faqat naqd pul va debitorlik qarzlari yordamida o'zining zudlik bilan bajarilishi lozim bo'lgan majburiyatlarini qoplash qobiliyatini o'lchaydi. Joriy tezkor koeffitsientni tahlil qilish Grace Therapeutics, Inc. (GRCE) moliyaviy barqarorligini tasdiqlaydi, bu yerda patent monopoliyalari va kamyob kasalliklar dori vositalarining yuqori marjasi kapitalning barqaror kirimi va kelajakdagi pul oqimlarining bashorat qilinuvchanligini ta'minlaydi.
Grace Therapeutics, Inc. kimlar bilan raqobatlashadi
Biogen Corp (BIIB) - Tezkor likvidlik|Shoshilinch likvidlik Neurocrine Corp (NBIX)|RGC (Regencell Bioscience) - Tezkor likvidlik koeffitsiyenti|AXSM - Kritik likvidlik|Tezkor likvidlik ACADIA Pharmaceuticals Inc. (ACAD)|XENE (Xenon Pharmaceuticals Inc.) - Oraliq qoplash koeffitsiyenti|Tezkor likvidlik koeffitsiyenti VKTX (Viking Pharma)|Tezkor likvidlik koeffitsiyenti Supernus Corp SUPN|Catalyst Pharmaceuticals - Tezkor likvidlik koeffitsiyenti|denalitherapeutics.com (DNLI) - Tezkor likvidlik ko‘rsatkichi|HRMY: Tezkor likvidlik koeffitsiyenti|Shoshilinch likvidlik Biohaven Ltd (BHVN)|Tezkor likvidlik ko‘rsatkichi AMLX|TRVI: Oraliq qoplash koeffitsiyenti|Tezkor likvidlik ko‘rsatkichi PRAX (Praxis Precision Medicines)|Oraliq likvidlik koeffitsiyenti AVXL|Tezkor likvidlik koeffitsiyenti CBLL (CeriBell)|Oraliq qoplash koeffitsiyenti PRTA|Alector Therapeutics - Tezkor likvidlik koeffitsiyenti|Shoshilinch likvidlik Annexon Biosciences Inc.|omeros.com (OMER) - Tezkor likvidlik|neurogene.com - Oraliq qoplash koeffitsiyenti|ACIU (AC Immune SA) - Tezkor likvidlik koeffitsiyenti|Tezkor likvidlik koeffitsiyenti Voyager Therapeutics Inc|Tezkor likvidlik Neumora Therapeutics Inc (NMRA)|SCLX: Kritik likvidlik koeffitsiyenti|Tezkor likvidlik koeffitsiyenti TVGN (Tevogen Bio Holdings)|Alpha Cognition Inc (ACOG) - Shoshilinch likvidlik|CGTX: Tezkor likvidlik ko‘rsatkichi|IKT - Tezkor likvidlik koeffitsiyenti|SAVA (Cassava) - Tezkor likvidlik ko‘rsatkichi|ASRT: Oraliq likvidlik koeffitsiyenti|COYA (Coya Therapeutics Inc) - Tezkor likvidlik koeffitsiyenti|VistaGen Therapeutics Inc (VTGN) - Oraliq qoplama koeffitsiyenti|Tezkor likvidlik koeffitsiyenti OVID|Tezkor likvidlik ko‘rsatkichi Acumen Pharmaceuticals Inc. ABOS|Tezkor likvidlik CervoMed Inc CRVO|Oraliq qoplama koeffitsiyenti Alterity Therapeutics Ltd. (ATHE)|CLNN: Tezkor likvidlik ko‘rsatkichi|Oraliq qoplash koeffitsiyenti PEPG (PepGen Inc.)|JUNS: Tezkor likvidlik koeffitsiyenti|RLMD - Oraliq qoplama koeffitsiyenti|Tezkor likvidlik Annovis Bio Corp|Shoshilinch likvidlik koeffitsiyenti AIFF (Firefly Neuro)|Tezkor likvidlik koeffitsiyenti KLTO|Tezkor likvidlik ko‘rsatkichi neurosense-tx.com NRSN|Reviva Pharmaceuticals Holdings, Inc. - Tezkor likvidlik ko‘rsatkichi|Oraliq qoplama koeffitsiyenti MetaVia Inc. (MTVA)|NeurAxis, Inc - Tezkor likvidlik koeffitsiyenti|Kritik likvidlik Helius Medical (HSDT)|passagebio.com (PASG) - Tezkor likvidlik|Neuphoria Therapeutics - Oraliq qoplash koeffitsiyenti|NERV (Minerva Neurosciences, Inc.) - Tezkor likvidlik koeffitsiyenti|Tezkor likvidlik ko‘rsatkichi Athira Pharma Inc (ATHA)|Tezkor likvidlik koeffitsiyenti ADXN|ALZN - Shoshilinch likvidlik|Tezkor likvidlik Cyclerion Therapeutics, Inc. CYCN|PTIX: Shoshilinch likvidlik koeffitsiyenti|Pasithea - Tezkor likvidlik koeffitsiyenti|Shoshilinch likvidlik Cortigent, Inc.|ATXI (Avenue Therapeutics, Inc) - Tezkor likvidlik ko‘rsatkichi|BrainStorm Cell Therapeutics Inc. (BCLI) - Tezkor likvidlik koeffitsiyenti|Tezkor likvidlik Cara Therapeutics, Inc.|CHRO: Oraliq qoplash koeffitsiyenti|Tezkor likvidlik Eliem Therapeutics (ELYM)|ITCI - Shoshilinch likvidlik|Tezkor likvidlik koeffitsiyenti LBPH (Longboard Pharma)|Kritik likvidlik Marinus Pharma|NKGN - Tezkor likvidlik|Oraliq qoplash koeffitsiyenti NRBO (neurobopharma.com)|SAGE: Tezkor likvidlik koeffitsiyenti|Synaptogenix Inc. (SNPX) - Tezkor likvidlik koeffitsiyenti|TRVN (Trevena, Inc) - Tezkor likvidlik koeffitsiyenti|Tezkor likvidlik ko‘rsatkichi Vigil Neuro (VIGL)|Tezkor likvidlik koeffitsiyenti WENA|CERE - Shoshilinch likvidlik